Guidelines and recommendations
Here you will find the current DZK guidelines on the diagnosis and treatment of tuberculosis, recommendations for environmental testing and infection prevention in tuberculosis as well as statements for special treatment situations.
New recommendations for environmental testing for tuberculosis (2023)
New recommendations for environmental testing for tuberculosis (2023)
Infection prevention & hygiene for tuberculosis (2023)
TNF-α inhibitors and biologics (non-TNF-α inhibitors)
Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals
TNF-α inhibitors and biologics (non-TNF-α inhibitors)
Recommendations for tuberculosis screening prior to administration of TNF-α inhibitors in rheumatic diseases
Pregnancy
Tuberculosis screening in pregnant women in the context of Section 36 (4) of the Infection Protection Act (IfSG) (2016)
Interferon-gamma release assays (IGRAs)
Current issues in tuberculosis screening with interferon-gamma release assays (IGRAs) (2015)
Recommendations for the diagnosis and treatment of non-tuberculous mycobacterioses (2013)
Recommendations for the diagnosis and treatment of non-tuberculous mycobacterioses from the German Central Committee for the Control of Tuberculosis (DZK) and the German Society for Pneumology and Respiratory Medicine (DGP) (2013)
Non-tuberculous mycobacteria
Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses. (2016)